Tenet Healthcare Corporation
US ˙ NYSE ˙ US88033G4073

SecurityTHC / Tenet Healthcare Corporation
InsiderRichard J Mark
This page shows the track record and history of MARK RICHARD J insider trades in Tenet Healthcare Corporation. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Richard J Mark in THC / Tenet Healthcare Corporation. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

THC / Tenet Healthcare Corporation Insider Trades
Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Richard J Mark in THC / Tenet Healthcare Corporation. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2024-03-12 14,000 98.9800 14,000 98.9800 1,385,720 37 91.0800 -110,600 -7.98
2022-03-09 6,000 90.4700 6,000 90.4700 542,820

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

THC / Tenet Healthcare Corporation Insider Trades
Insider Transaction History
File
Date
Trade
Date
Form Insider Ticker Security Title Code 10b5-1 Direct Exercise
Price
Unit
Price
Units
Changed
Value
Changed (1K)
Remaining
Options
Remaining
Shares
2026-05-26 2026-05-22 4 MARK RICHARD J THC Common Stock D - Sale to Issuer D 173.7800 -493 -86 35,121
2026-05-26 2026-05-22 4 MARK RICHARD J THC Common Stock M - Exercise D 1,333 35,614
2025-05-27 2025-05-23 4 MARK RICHARD J THC Common Stock D - Sale to Issuer D 161.3300 -573 -92 34,281
2025-05-27 2025-05-23 4 MARK RICHARD J THC Common Stock M - Exercise D 1,551 34,854
2024-03-14 2024-03-12 4 MARK RICHARD J THC Common Stock S - Sale D 98.9800 -14,000 -1,386 33,303
2023-06-23 2023-05-26 4/A MARK RICHARD J THC Common Stock A - Award D 3,682 47,303
2023-05-30 2023-05-26 4 MARK RICHARD J THC Common Stock A - Award D 2,846 46,467
2022-05-11 2022-05-09 4 MARK RICHARD J THC Common Stock A - Award D 3,836 43,621
2022-03-10 2022-03-09 4 MARK RICHARD J THC Common Stock S - Sale D 90.4700 -6,000 -543 39,785
2021-05-11 2021-05-07 4 MARK RICHARD J THC Common Stock A - Award D 3,960 45,785
2020-06-02 2020-05-29 4 MARK RICHARD J THC Common Stock A - Award D 11,139 41,825
2019-05-07 2019-05-03 4 MARK RICHARD J THC Common Stock A - Award D 10,817 30,686
2018-05-08 2018-05-04 4 MARK RICHARD J THC Common Stock A - Award D 7,439 19,869
2017-12-04 2017-11-30 4 MARK RICHARD J THC Common Stock A - Award D 12,430 12,430
P
Offener Markt oder privater Kauf von nicht-derivativen oder derivativen Wertpapieren
S
Freiverkauf oder privater Verkauf von nicht-derivativen oder derivativen Wertpapieren
A
Gewährung, Vergabe oder sonstiger Erwerb von Wertpapieren des Unternehmens (z. B. eine Option)
C
Umwandlung von Derivaten
D
Verkauf oder Rückübertragung von Wertpapieren an das Unternehmen
F
Zahlung des Ausübungspreises oder der Steuerschuld mit einem Teil der vom Unternehmen erhaltenen Wertpapiere
G
Schenkung von Wertpapieren durch oder an den Insider
K
Aktien-Swaps und ähnliche Absicherungstransaktionen
M
Ausübung oder Umwandlung eines vom Unternehmen erhaltenen derivativen Wertpapiers (z. B. einer Option)
V
Eine freiwillig auf Formular 4 gemeldete Transaktion
J
Sonstige (mit einer Fußnote zur Beschreibung der Transaktion)